Promacta tended to boost platelet counts in patients with low-risk MDS, and helped those patients be independent of transfusions, too. Promacta (eltrombopag) improved platelet counts in patients with ...
Platelet transfusion thresholds in according bleeding risk and the presence of bleeding. WHO = World Health Organization. “In practice, we see all too often [that] prophylactic transfusion of ...
In a new paper, researchers from University Hospitals (UH) detail how they used data via a dashboard to decrease the use of packed red-blood cell (pRBC) transfusions and platelets with an increase in ...
APR-246, a new class anticancer compound in phase l/lla clinical trials. An open-label randomized phase II trial of belinostat (PXD101) in combination with carboplatin and paclitaxel (BelCaP) compared ...
People with MDS have fewer red and white blood cells and platelets. Blood transfusions may be needed if you have MDS and experience anemia or thrombocytopenia. Myelodysplastic syndromes (MDS) are a ...
Comprehensive insight on potential complications that can occur during transfusion therapy for myelodysplastic syndrome. Transcript: Bart Scott, MD, MS: Many patients wonder about what the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results